Claims for Patent: 5,783,558

Summary for Patent: 5,783,558

Title:	Parathormone fragments, their preparation and medicaments containing these
Abstract:	The invention concerns parathormone (PTH) fragments including the amino acid range of the natural parathormone of +3 to +35 and their physiologically compatible derivatives, a process for the preparation of the fragments according to the solid phase and liquid phase synthesis from partly blocked amino acids contained in the fragments which are coupled with one another in the sequence which corresponds to the amino acid sequence in the fragments to be prepared and medicaments containing at least one of the fragments, especially with calcium-regulating action in the body.
Inventor(s):	Duvos; Christian (Stade, DE), Mayer; Hubert (Wolfenbuttel, DE), Mueller-Beckmann; Bernd (Grunstadt, DE), Strein; Klaus (Hemsbach, DE), Wingender; Edgar (Wolfenbuttel, DE)
Assignee:	Boehringer Mannheim GmbH (Mannheim, DE)
Application Number:	08/256,363
Patent Claims:	1. A peptide fragment of a parathyroid hormone (PTH) selected from the group consisting of bovine PTH beginning at residue 1 and ending a residue 35 or 36; and porcine PTH beginning at residue 1 and ending at residue 35 or 36. 2. A process for the preparation of a peptide of claim 1, comprising: synthesizing fragments by solid phase and liquid phase synthesis from protected amino acids; splitting off the fragments and the protecting groups; and precipitating the synthesized fragments. 3. The process of claim 2, wherein the synthesized PTH fragments are purified by chromatography processes. 4. A pharmaceutical composition comprising a peptide of claim 1 and a pharmaceutically acceptable excipient. 5. The pharmaceutical composition of claim 4, wherein the peptide is in amounts of from 300 microgram to 30 milligram per therapy unit. 6. The pharmaceutical composition of claim 4 wherein the composition has the property of calcium-regulation. 7. The pharmaceutical composition of claim 4 wherein the composition has the property of promoting the incorporation of calcium into the bones. 8. A method of regulating calcium levels in the body comprising administering to a patient in need of such regulating an effective amount of the peptide of claim 1. 9. A method of increasing incorporation of calcium into the bones comprising administering to a patient in need of such treatment an effective amount of the peptide of claim 1. 10. A method of treatment of osteoporosis comprising administering to a patient in need of such treatment an effective amount of the peptide of claim 1.

Details for Patent 5,783,558

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2015-07-21